← All trials
NCT02941159
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2016
- Primary completion
- Nov 1, 2016
- Completion date
- Nov 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 43
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Tropical Diseases Research Centre, ZambiaLead sponsor
- University of ZambiaCollaborator
- National AIDS/TB/STIs Council of ZambiaCollaborator
- Copperbelt University of ZambiaCollaborator
- Dr Ludwick Sondashi Formular ClinicCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.